Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Saliva Diagnostics (SALV) -- Ignore unavailable to you. Want to Upgrade?

To: Shadow who wrote (2008)	2/4/1998 11:03:00 AM
From: Frank Brisebois	Read Replies (1) \| Respond to of 3369

SALV should change their name to SUCKER

To: Shadow who wrote (2008)	2/4/1998 2:48:00 PM
From: Keiko	Read Replies (2) \| Respond to of 3369

Pretty grim..... I'm showing 430,000 shares traded.

To: Shadow who wrote (2008)	2/5/1998 10:24:00 AM
From: John Lacelle	Respond to of 3369

Tom, I bet you are right. I can almost see the press releases now: "SDS to See Profitablity in 1998" "SDS to Produce Saliva-based HIV Antibody Test"...oh sorry, thats an old one from the 1996 prospectus. Actually, if they could produce a saliva based test that would indicate a propensity for stock fraud, there might be a market. Just for fun, we should start a "pool" to see who can come the closest to the reverse split ratio that is going to occur. I'll go first. I forecast a reverse split of 20-1 so that by March 1 1998 SALV will be selling for about $1.00 per share. What does everyone else think? -John